Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719999 | SCV000515528 | likely benign | not provided | 2018-09-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000463263 | SCV000562740 | likely benign | Juvenile polyposis syndrome | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000562816 | SCV000668329 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000562816 | SCV000903824 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-09 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000428241 | SCV001469367 | benign | not specified | 2019-12-17 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000463263 | SCV005406655 | benign | Juvenile polyposis syndrome | 2024-08-08 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
True Health Diagnostics | RCV000562816 | SCV000787889 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-10 | no assertion criteria provided | clinical testing |